- OraSure Technologies Supports National HIV Testing Day
- OraSure Reports Q1 ’24 Revenue of $54.1 Million
- OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th
- OraSure Reports Q4 ‘23 Revenue of $75.9 Million
- OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th
- OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Generation Consumer Diagnostics Company
- OraSure to Participate in Upcoming Investor Conferences
- OraSure Reports Q3 ‘23 Revenue of $89.2 Million; Core Revenue Grows 7% Year-over-Year
- OraSure to Announce Third Quarter 2023 Financial Results and Host Earnings Call on November 7th
- OraSure Reports Q2 ‘23 Revenue of $85.4 Million; Core Revenue Grows 3% Year-over-Year
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.76 |
---|---|
High | 3.76 |
Low | 3.76 |
Bid | 3.76 |
Offer | 3.82 |
Previous close | 3.94 |
Average volume | 56.67 |
---|---|
Shares outstanding | 73.96m |
Free float | 71.69m |
P/E (TTM) | 13.42 |
Market cap | 301.75m USD |
EPS (TTM) | 0.304 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 07:20 BST.
More ▼